Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Learn more about whether Globus Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ ...

Shares of NYSE GMED opened at $73.35 on Tuesday. Globus Medical has a twelve month low of $49.33 and a twelve month high of $94.93. The firm has a fifty day simple moving average of $84.13 and a ...

Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports.

Mapletree Medical Clinic, part of Independent Physicians of Wisconsin, opened a new independent medical practice in Sturgeon Bay March 17. The clinic provides adult primary care and internal medicine ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...